Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Still a Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares gapped up prior to trading on Tuesday. The stock had previously closed at $11.00, but opened at $12.10. Ambu A/S shares last traded at $12.10, with a volume of 438 shares traded.

Analysts Set New Price Targets

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Ambu A/S currently has a consensus rating of “Hold”.

Ambu A/S Stock Performance

The firm has a market capitalization of $2.84 billion, a P/E ratio of 40.33 and a beta of 0.93. The company’s 50 day moving average is $11.00 and its 200-day moving average is $11.00. The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%. The business had revenue of $255.12 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.